Skip to content

A clinical trial to study the effect of two drugs, Khandshunthi and Aamvatagajasimha Modak in patients with Aamvata with special reference to Chronic Rheumatoid Arthritis

An Open Randomized Comparative clinical study of Khandshunthi (Bhavprakash) with Aamvatagajasimha Modak (Rasendra Sara Sangraha) in the management of Aamvata. - Nil

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/066476
Enrollment
60
Registered
2024-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M060- Rheumatoid arthritis without rheumatoid factor

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: (1) patient in age group of 16 years to 70 years (2) patients of all genders will be included (3) patients having classical signs and symptoms of jeerna aamvata (4) Patients having RA positive or negative will be selected on the basis of ayurvedic diagnosis of jeerna aamvata

Exclusion criteria

Exclusion criteria: (1) Pregnant women and lactating mothers (2) Serious systemic disorders like diabetes mellitus, malignancy, renal failure (3) If patient is not willing (4) Patients with steroid dependency

Design outcomes

Primary

MeasureTime frame
Complete cell count Erythrocyte sedimentation rate C - reactive protein Body weightTimepoint: 28 days

Secondary

MeasureTime frame
Sandhishool (Joint pain) Sandhigrah (Joint stiffness) Angamard (Bodyache) Aruchi (Ageusia) Kshudhamandya (Anorexia) Malavashtambha (Constipation) Jwaranubhuti (Feverish sensation)Timepoint: 28 days

Countries

India

Contacts

Public ContactDr Nikita Sanjay Vekhande

APMs, Ayurveda Mahavidyalaya, Sion, Mumbai

anayapathrikar@gmail.com9870214595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026